Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic changes during prostate cancer development and progression
Alicia-Marie K. Beier, Martin Puhr, Matthias B. Stope, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 2259-2270
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Cancer stem cell in prostate cancer progression, metastasis and therapy resistance
Poornima Verma, Neha Shukla, Shivani Kumari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188887-188887
Closed Access | Times Cited: 36
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Lactoferrin-Encapsulated Dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer
Sugarniya Subramaniam, Varinder Jeet, Jennifer H. Gunter, et al.
Cancer Letters (2025), pp. 217522-217522
Closed Access | Times Cited: 1
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium
Sherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
Alicia-Marie K. Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Oncogene (2024) Vol. 43, Iss. 26, pp. 2038-2050
Open Access | Times Cited: 5
Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers
Eva Chrenková, Hana Študentová, Kateřina Holá, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Enhancing Radiation Therapy Response in Prostate Cancer Through Metabolic Modulation by Mito-Lonidamine: A 1H and 31P Magnetic Resonance Spectroscopy Study
Stepan Orlovskiy, Pradeep Kumar Gupta, Fernando Arias‐Mendoza, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 509-509
Open Access
The prognostic and neuroendocrine implications of SLC25A29-mediated biomass signature in prostate cancer
Chia-Chang Wu, Su-Wei Hu, Shaowei Dong, et al.
GeroScience (2025)
Closed Access
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis
Mohsin Raza, Asher Rajkumar Rajan, Benjamin B. Kennedy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
An update understanding of stemness and chemoresistance of prostate cancer
Afiya Wahab, Hifzur R. Siddique
Expert Review of Anticancer Therapy (2025)
Closed Access
Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell–cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer
Danial Hashemi Karoii, Ali Shakeri Abroudi, Nadia Forghani, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, et al.
Molecular Oncology (2025)
Open Access
Estrogen-related receptor alpha (ERRα) controls the stemness and cellular energetics of prostate cancer cells via its direct regulation of citrate metabolism and zinc transportation
Taiyang Ma, Wenjuan Xie, Zhenyu Xu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Assessing novel analogues of nilutamide as a human androgen receptor antagonist: A detailed investigation of drug design using a bioisosteric methodology including ADMET profiling, molecular docking studies and molecular dynamics simulation
Ajay Gupta, Yogita Sahu, Dipti Pal, et al.
Computational Biology and Chemistry (2025), pp. 108424-108424
Closed Access
Foot-and-mouth disease virus activates glycolysis and hijacks HK2 to inhibit innate immunity and promote viral replication
Wenxian Chen, Xinyan Wang, Xiaowen Li, et al.
Veterinary Research (2025) Vol. 56, Iss. 1
Open Access
Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer
Daniel Evin, Andrea Evinová, Eva Baranovičová, et al.
(2024)
Open Access | Times Cited: 2
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Takuma Uo, Kayode K. Ojo, Cynthia C.T. Sprenger, et al.
Molecular Cancer Therapeutics (2024), pp. OF1-OF22
Open Access | Times Cited: 2
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium
Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH
Xian Fu, Hongshen Wu, Chang‐Jiu Li, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 9, pp. 2415-2427
Open Access | Times Cited: 6
Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications
José María Mora-Rodríguez, Belén G. Sánchez, Alba Sebastián-Martín, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15626-15626
Open Access | Times Cited: 4
Expressions of glucose transporter genes are diversely attenuated and significantly associated with prostate cancer progression.
Hua Huang, Shiqi Song, Wang Liu, et al.
PubMed (2023) Vol. 11, Iss. 6, pp. 578-593
Closed Access | Times Cited: 4
Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer
Daniel Evin, Andrea Evinová, Eva Baranovičová, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2630-2630
Open Access | Times Cited: 1
Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer
S. F. Smith, Daniel Brewer, Rachel Hurst, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1717-1717
Open Access | Times Cited: 1
Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer
Fengxia Lin, Long Yan, Mingyue Li, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32914-e32914
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top